Stock 605077 ZHEJIANG HUAKANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Zhejiang Huakang Pharmaceutical Co., Ltd.

Equities

605077

CNE100005477

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 02/06/2024 BST 		5-day change 1st Jan Change
16.21 CNY -1.28% Intraday chart for Zhejiang Huakang Pharmaceutical Co., Ltd. -6.55% -2.62%
04-25 Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-18 Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.
CI
Zhoushan Huakang Biotechnology Co., Ltd. announced that it expects to receive CNY 700 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.
CI
Huakang Pharmaceutical Earmarks 248 Million Yuan for Corn Oil, Maltodextrin Plants
MT
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(XSSC:605077) added to S&P Global BMI Index
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
HY Energy Plans to Sell Remaining Stake in Huakang Pharma
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Zhejiang Huakang Pharma Selling 1.3 Billion Yuan Convertible Bonds to Fund New Factory
MT
Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077completed the acquisition of 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd.
CI
Zhejiang Huakang Pharma to Buy 95% of Thermal Power Firm for 522.5 Million Yuan
MT
Zhejiang Huakang Pharmaceutical Co., Ltd. agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million.
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
HY Energy Plans to Unload Stake in Zhejiang Huakang Pharma
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Jiaozuo Huakang Sugar Alcohol Technology Co., Ltd. announced that it expects to receive CNY 295.8671 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.
CI
Ningbo Traditional Chinese Pharmaceutical Corp. announced that it has received CNY 21.97644 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd.
CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 605077 Stock
  4. News Zhejiang Huakang Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW